Nello Mainolfi is Founder, President and Chief Executive Officer of Kymera Therapeutics, Inc. (KYMR). The company reported total compensation of $8,545,609 for fiscal year 2025.
| Salary | $693,000 |
|---|---|
| Bonus | $0 |
| Stock awards | $0 |
| Option awards | $7,318,859 |
| Non-equity incentive plan | $519,750 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $14,000 |
| Total | $8,545,609 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Kymera Therapeutics, Inc. filed April 29, 2026, accession 0001193125-26-191495.
| Peer-group chief executive median | $12,794,230 |
|---|---|
| Difference from that median | $-4,248,620 |
| Percentile within the disclosed peer group | 29th |
| Peers with a disclosed figure | 14 |
Medians and percentiles are computed across the peer group Kymera Therapeutics, Inc. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Nello Mainolfi this page | Founder, President and Chief Executive Officer | $8,545,609 |
| Brian Adams | Chief Legal Officer | $6,071,041 |
| Noah Goodman | Chief Business Officer | $3,172,068 |
| Jared Gollob | Chief Medical Officer | $2,914,330 |
| Bruce Jacobs | Chief Financial Officer | $2,903,236 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Kymera Therapeutics, Inc. compensation brief.
Nello Mainolfi's compensation sits inside Kymera Therapeutics, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.